Tata Memorial Centre, Mumbai, and Vedanta BALCO Medical Centre, Raipur, sign MoU
17th September 2022
- Aims for driving excellence in cancer care through knowledge exchange and enhancement of skills, capabilities and core practices
Mumbai; 17th September 2022: The Tata Memorial Centre (TMC), Mumbai, and Vedanta Medical Research Foundation’s flagship initiative, BALCO Medical Centre (BMC), Raipur, Chhattisgarh, have entered into a memorandum of understanding (MOU) today to drive excellence in cancer care in the country. The MoU was signed between Dr. R. A. Badwe, Director of Tata Memorial Centre, and Dr. Bhawna Sirohi, Medical Director of BALCO Medical Centre, at Tata Memorial Hospital, Parel, in the presence of Mrs. Jyoti Agarwal, Chairperson of BALCO Medical Centre. Mrs. Jyoti Agarwal was also the Chief Guest of the event.
As per the MoU, the BALCO Medical Centre and Tata Memorial Centre will join forces for exchange of knowledge, and enhancement of skills, capabilities and core practices. BMC will leverage TMC’s expertise and decades of experience in cancer treatment for developing best-in-class technical and medical guidelines. With this association, TMC will also empanel BMC as a referral centre for patients from Chhattisgarh, and neighbouring states. Both cancer hospitals have mutually agreed to:
- Share best practices and evolving knowledge on cancer treatment
- BMC will take part in the National Cancer Grid Virtual Tumour Boards to drive excellence in patient care
- Mutually conduct and participate in continuing medical education (CME) sessions at both the locations
- Conduct joint research or multi-centric trials
Elated with the association, Mrs. Jyoti Agarwal, Chairperson of BALCO Medical Centre, said, “This is a significant moment in the history of cancer care in India, when Tata Memorial Centre and BALCO Medical Centre are coming together to partake in knowledge sharing and jointly bring about a transformation in cancer care with values of compassion, care and cure. When we started the BALCO Medical Centre 4 years ago, we set ourselves on a relentless mission of providing world-class and affordable cancer care to all by becoming the go-to cancer care provider in Central India. Now, with this MoU, I look forward to the next phase of our growth, wherein, together, we will learn more and find new ways to serve communities better.”
Medical Director of the BALCO Medical Centre, Dr Bhawna Sirohi, said, “We, at BALCO Medical Centre, have a combination of some of the best talent and technology to become a cancer care leader in the country. BMC has made available holistic and world-class cancer treatment to central India under one roof. Now, it is time to spread our wings farther by collaborating with TMC for mutual learning and knowledge, including staff training, educational sessions, institutional fellowships, cross-referrals of patients and joint research, which will shape the future of cancer care in India.”
Dr. Sirohi, who is the torchbearer of this association from BMC, is also the Founder-President of New India Cancer Charity Initiative, which has led clinical screening for breast, cervical and head & neck cancer in rural India. She is presently on the management committee of ‘CanSupport’ and is a patron for ‘Voice of Tobacco Victims’. She brings with her decades of expertise in the National Health Service in UK, TMC and various corporate cancer centres in India. She is actively involved with the National Cancer Grid, Indian Council of Medical Research, for guideline development and quality improvement initiatives.
Speaking about the association with BALCO Medical Centre, Dr. R. A. Badwe, Director of Tata Memorial Centre, said, “Tata Medical Centre has a track record of driving excellence in cancer care globally and aims to empower as many centres in India to drive the same vision of excellence in service, research and education. I have been closely associated with Balco Medical Centre and have seen their zeal to give high-quality and evidence-based cancer treatment to all patients who come to seek treatment. This association will help us to collaborate with the experts from BMC for mutual exchange of knowledge and conduct cancer research jointly. Interactions such as these will also allow assessment of viability of any new idea amongst experts in both the organizations”
Tata Memorial Centre is amongst the oldest and largest cancer centres in the world, with over 75 years of exceptional patient care, high-quality training and innovative cancer research.
Looking at the rising incidence of cancer as a health threat and lack of quality cancer care centres in tier 2 and 3 cities, Vedanta established BALCO Medical Centre at Raipur to provide affordable comprehensive cancer care to all the sections of the society. Since its inception in March 2018, the BALCO Medical Centre, a comprehensive cancer care hospital, has been garnering trust for its compassionate and quality cancer care. It is one of the most preferred facilities in the region for advanced radiation therapy, brachytherapy, nuclear medicine, surgeries, chemotherapy, immunotherapy, targeted therapy, blood-related disorders, bone marrow transplant, plastic and reconstructive surgery, pain & palliative care.
For more information, visit www.balcomedicalcentre.com
About Vedanta Limited:
Vedanta Limited, a subsidiary of Vedanta Resources Limited, is one of the world’s leading Oil & Gas and Metals company with significant operations in Oil & Gas, Zinc, Lead, Silver, Copper, Iron Ore, Steel, and Aluminium & Power across India, South Africa and Namibia. For two decades, Vedanta has been contributing significantly to nation building. Governance and sustainable development are at the core of Vedanta's strategy, with a strong focus on health, safety, and environment. Vedanta has put in place a comprehensive framework to be the ESG leader in the natural resources sector. Vedanta is committed to reducing carbon emissions to zero by 2050 or sooner and has pledged $5 billion over the next 10 years to accelerate the transition to net zero operations. Giving back is in the DNA of Vedanta, which is focused on enhancing the lives of local communities. The company’s flagship social impact program, Nand Ghars, have been set up as model anganwadis focused on eradicating child malnutrition, providing education, healthcare, and empowering women with skill development. Under the aegis of the Anil Agarwal Foundation, the umbrella entity for Vedanta’s social initiatives, the Vedanta group has pledged Rs 5000 crore over the next five years on social impact programmes with a thrust on nutrition, women & child development, healthcare, animal welfare, and grass-root level sports. Vedanta and the group companies have been featured in Dow Jones Sustainability Index, and was conferred Frost & Sullivan Sustainability Awards 2020, Golden Peacock Award for excellence in Corporate Governance 2022 and certified as a Great Place to Work 2022. Vedanta Limited is listed on the Bombay Stock Exchange and the National Stock Exchange.
For more information, please visit www.vedantalimited.com
About Vedanta Aluminium Business:
Vedanta Aluminium, a business of Vedanta Limited, is India’s largest producer of aluminium, manufacturing more than half of India’s aluminium i.e., 2.37 million tonnes in FY24. It is a leader in value-added aluminium products that find critical applications in core industries. Vedanta Aluminium ranks 1st in the S&P Global Corporate Sustainability Assessment 2023 world rankings for the aluminium industry, a reflection of its leading sustainable development practices. With its world-class aluminium smelters, alumina refinery and power plants in India, the company fulfils its mission of spurring emerging applications of aluminium as the ‘Metal of the Future’ for a greener tomorrow.
For more information, please log on to www.vedantaaluminium.com
Follow us on LinkedIN, Facebook, Twitter, Instagram
Disclaimer:
This press release contains “forward-looking statements” – that is, statements related to future, not past, events. In this context, forward-looking statements often address our expected future business and financial performance, and often contain words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “should” or “will.” Forward-looking statements by their nature address matters that are, to different degrees, uncertain. For us, uncertainties arise from the behaviour of financial and metals markets including the London Metal Exchange, fluctuations in interest and or exchange rates and metal prices; from future integration of acquired businesses; and from numerous other matters of national, regional, and global scale, including those of a political, economic, business, competitive or regulatory nature. These uncertainties may cause our actual future results to be materially different than those expressed in our forward-looking statements. We do not undertake to update our forward-looking statements.
